Adicet Bio, Inc.ACETNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +104.17% | +15.18% | +0.50% | +0.26% | +25.49% |
| Weighted Average Shares Diluted Growth | +104.17% | +15.18% | +0.50% | +0.26% | +25.49% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | -19.52% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +6.23% | -34.74% | -39.38% | -42.89% | -12.65% |
| Book Value per Share Growth | -46.29% | -45.84% | -43.56% | -48.54% | -32.01% |
| Debt Growth | -17.64% | -18.92% | -19.73% | -14.63% | -14.48% |
| R&D Expense Growth | -6.00% | -4.53% | +9.74% | -12.95% | +7.58% |
| SG&A Expenses Growth | +9.74% | +32.84% | -42.89% | -26.10% | -8.31% |